A distinct syndrome including features of systemic sclerosis, erosive rheumatoid arthritis, anti-topoisomerase antibody, and rheumatoid factor.

A distinct syndrome including features of systemic sclerosis, erosive rheumatoid arthritis, anti-topoisomerase antibody, and rheumatoid factor.

Podrobná bibliografie
Hlavní autoři:	Doran, M, Wordsworth, P, Bresnihan, B, Fitzgerald, O
Médium:	Journal article
Jazyk:	English
Vydáno:	2001

Podobné jednotky

Rheumatoid arthritis.
Autor: Wordsworth, P
Vydáno: (1992)

The immunogenetics of rheumatoid arthritis.
Autor: Wordsworth, P
Vydáno: (1990)

Anti-chromatin antibodies in juvenile rheumatoid arthritis
Autor: F. Ingegnoli, a další
Vydáno: (2003-12-01)

The immunogenetics of rheumatoid arthritis.
Autor: Wordsworth, B, a další
Vydáno: (1992)

Progress in the immunogenetics of rheumatoid arthritis.
Autor: Wordsworth, P
Vydáno: (1995)

Diagnostic value of Anti-CCP antibodies compared with Rheumatoid factor in Rheumatoid arthritis patients.
Autor: Hanaa N. Abdullah, a další
Vydáno: (2013-08-01)

Genetic epidemiology of rheumatoid arthritis.
Autor: Harney, S, a další
Vydáno: (2002)

Specificity of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis
Autor: Nicole H. Trier, a další
Vydáno: (2019-06-01)

Time to include fine specificity anti‐citrullinated protein antibodies in the routine diagnosis and management of rheumatoid arthritis?
Autor: Schwenzer, A, a další
Vydáno: (2018)

Overlap between systemic sclerosis and rheumatoid arthritis: a distinct clinical entity?
Autor: Alex Magno Coelho Horimoto, a další

Polygenic susceptibility in rheumatoid arthritis.
Autor: Wordsworth, B, a další
Vydáno: (1991)

Antibody therapy for rheumatoid arthritis.
Autor: Taylor, P
Vydáno: (2003)

Antikeratin antibodies in rheumatoid arthritis
Autor: J Zabek
Vydáno: (2003-02-01)

Molecular genetics of rheumatoid arthritis.
Autor: Harney, S, a další
Vydáno: (2003)

ANTI-HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN B1 (ANTI-RA33) ANTIBODIES IN RHEUMATOID ARTHRITIS AND SYSTEMIC SCLEROSIS
Autor: P. A. Kuznetsova, a další
Vydáno: (2017-04-01)

T cell genetics and rheumatoid arthritis (RA)
Autor: Wordsworth, P
Vydáno: (1998)

Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis
Autor: Stefano Alivernini, a další
Vydáno: (2019-05-01)

The Diagnostic Utility of Anti-cyclic Citrullinated Peptide Antibodies, Matrix Metalloproteinase-3, Rheumatoid Factor, Erythrocyte Sedimentation Rate, and C-reactive Protein in Patients with Erosive and Non-erosive Rheumatoid Arthritis
Autor: O. Shovman, a další
Vydáno: (2005-01-01)

Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis.
Autor: Feldmann, M, a další
Vydáno: (1994)

The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis
Autor: Hui-Chun Yu, a další
Vydáno: (2019-01-01)

Erosive polyarthritis in multicentric reticulohistiocytosis mimics rheumatoid arthritis
Autor: Bagus Putu Putra Suryana, a další
Vydáno: (2018-02-01)

Comparism between Anti-RA33, Anti-CCP antibodies and Rheumatoid Factor in the Diagnosis of Rheumatoid Arthritis in Iraqi Patients
Autor: Ammar H. Al-Ubaidi, a další
Vydáno: (2013-04-01)

Clinical features of rheumatoid arthritis
Autor: Colquhoun, M, a další
Vydáno: (2022)

Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis
Autor: Nobuo Kuramoto, a další
Vydáno: (2017-07-01)

Erosive arthritis and anti-cyclic citrullinated peptide antibodies in systemic sclerosis
Autor: A Abdessemed, a další
Vydáno: (2017-01-01)

Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies
Autor: P. Airò, a další
Vydáno: (2011-09-01)

The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: The predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis
Autor: Heidari Behzad, a další
Vydáno: (2009-01-01)

Utility of anti-carbamylated protein antibodies in the diagnosis of early rheumatoid arthritis
Autor: Ashraf H Mohamed, a další
Vydáno: (2019-01-01)

Clinical and etiological meaning of anti-carbamylated protein antibodies in rheumatoid arthritis
Autor: Shuichiro Nakabo
Vydáno: (2019-01-01)

Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis
Autor: Haiting Wu, a další
Vydáno: (2022-04-01)

Association of rheumatoid factor and anti-cyclic citrullinated peptide antibody with demographic, clinical, and inflammatory parameters in rheumatoid arthritis
Autor: Rajat Sarkar, a další
Vydáno: (2023-01-01)

Relationship between bone mineral density and anti-citrullinated protein antibody and rheumatoid factor in patients with rheumatoid arthritis
Autor: Gökhan Sargın, a další
Vydáno: (2019-01-01)

Rheumatoid factor versus anti - cyclic citrullinated peptide antibody as screening tool for rheumatoid arthritis in an ophthalmic clinic
Autor: Prabhakar Singh, a další
Vydáno: (2020-01-01)

HLA class II antigens in susceptibility to rheumatoid arthritis.
Autor: Wordsworth, B
Vydáno: (1991)

Distinct biomarkers for different bones in osteoporosis with rheumatoid arthritis
Autor: T. Tomizawa, a další
Vydáno: (2019-07-01)

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
Autor: Feldmann, M, a další
Vydáno: (2011)

Anti-cytokine therapy for rheumatoid arthritis.
Autor: Maini, R, a další
Vydáno: (2000)

Evaluation of anti-citrullinated and anti-carbamylated antibodies in mexicans with rheumatoid arthritis and at-risk individuals
Autor: Edgar E. Lara-Ramírez, a další
Vydáno: (2024-01-01)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
Autor: Isaacs, J, a další
Vydáno: (1992)

Humanized monoclonal antibody treatment in rheumatoid arthritis.
Autor: Kyle, V, a další
Vydáno: (1991)